Categories: News

Therap is Announcing its Interface with the Electronic Visit Verification (EVV) Data Aggregator for the District of Columbia’s (DC) Department of Health Care Finance’s (DHCF) MMIS

WATERBURY, Conn., Dec. 3, 2020 /PRNewswire/ — Therap is announcing the release of its interface to Sandata, DHCF’s mandated EVV data aggregator. With the interface Therap’s EVV / Scheduling application provides seamless HIPAA compliant claims processing in compliance with the Section 12006 of the 21st century CURES Act. DHCF requires EVV data for claims for Participant-Directed Community Support (PDCS) services in the EPD and IDD Waivers. Therap’s documentation and Billing system supports service delivery for DC providers as well as providers in all US states with EPD and IDD waivers. Therap’s EVV application is primarily used with smartphones or tablets with GPS functionality and also supports offline check-in, Interactive Voice Response (IVR) and Fixed Visit Verification (FVV) as alternative methods of verification for situations where internet connectivity is limited or not available. The EVV application has reporting features for capabilities including attestation, service verification and caregiver tasks.

Therap’s interface with Sandata / DHCF accumulates information on staff and individuals during visits for service provision that meet the Federally required data elements for EVV claims:

  1. Type of service performed
  2. Individual receiving the service
  3. Date of the service
  4. Location of service delivery
  5. Staff providing the service
  6. Begin and End Time of the service provided

In addition to the EPD and IDD waivers Therap is also monitoring the development of the joint DHCF / DDS Individual and Family Support (IFS) waiver and will be prepared to support that program when it is implemented.

The Sandata Interface upgrades Therap for current users processing claims with Billing and can be added as an upgrade for Therap users not currently using the Billing application. Therap also provides a comprehensive solution for service planning, tracking service delivery, and processing billing claims for prospective users. If implementing EVV in a timely manner is an issue, Therap’s application is a COTS and SaaS system that is bundled with training to provide a straightforward and rapid implementation.
Contact https://www.therapservices.net/products/electronic-visit-verification-solutions/ with any questions.

About Therap
Therap’s HIPAA-compliant Electronic Visit Verification software is widely used in home and community-based waiver services and other human services settings, including intellectual and developmental disabilities, aging, and home health for documentation, communication, billing and reporting.

Source: https://www.therapservices.net/electronic-visit-verification/

View original content:http://www.prnewswire.com/news-releases/therap-is-announcing-its-interface-with-the-electronic-visit-verification-evv-data-aggregator-for-the-district-of-columbias-dc-department-of-health-care-finances-dhcf-mmis-301185993.html

SOURCE Therap Services

Staff

Recent Posts

President Trump’s Cannabis Decision Is Coming – And Why MMJ International Holdings Wins Either Way

12 Month Timeline - How Cannabis Rescheduling Actually Takes EffectAnnouncementPresident signals intent or issues executive…

16 hours ago

Accelerating Patient Recruitment and Research Excellence: TrialWire® Supports Endpoints Clinical Trials Day NYC 2025

NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- TrialWire®, the industry’s fastest, intelligent patient recruitment…

22 hours ago

Genesis Healthcare Remains Committed to Securing Longterm Stability

The skilled nursing, assisted and senior living provider reiterates dedication to a financial restructuring process…

22 hours ago

Extendicare Announces December 2025 Dividend of C$0.042 per Share

MARKHAM, Ontario, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX:…

22 hours ago

Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026

TEL AVIV, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and…

22 hours ago